166 related articles for article (PubMed ID: 29552747)
1. Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.
Ledger S; Howe A; Turville S; Aggarwal A; Savkovic B; Ong A; Wolstein O; Boyd M; Millington M; Gorry PR; Murray JM; Symonds G
J Gene Med; 2018 Feb; 20(2-3):e3006. PubMed ID: 29552747
[TBL] [Abstract][Full Text] [Related]
2. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
[TBL] [Abstract][Full Text] [Related]
3. Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor.
Wolstein O; Boyd M; Millington M; Impey H; Boyer J; Howe A; Delebecque F; Cornetta K; Rothe M; Baum C; Nicolson T; Koldej R; Zhang J; Keech N; Camba Colón J; Breton L; Bartlett J; An DS; Chen IS; Burke B; Symonds GP
Mol Ther Methods Clin Dev; 2014; 1():11. PubMed ID: 26015947
[TBL] [Abstract][Full Text] [Related]
4. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.
Anderson JS; Javien J; Nolta JA; Bauer G
Mol Ther; 2009 Dec; 17(12):2103-14. PubMed ID: 19690520
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1.
Khamaikawin W; Saisawang C; Tassaneetrithep B; Bhukhai K; Phanthong P; Borwornpinyo S; Phuphuakrat A; Pasomsub E; Chaisavaneeyakorn S; Anurathapan U; Apiwattanakul N; Hongeng S
Sci Rep; 2024 May; 14(1):10852. PubMed ID: 38741006
[TBL] [Abstract][Full Text] [Related]
6. Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection.
Herrera-Carrillo E; Berkhout B
PLoS One; 2017; 12(5):e0177935. PubMed ID: 28542329
[TBL] [Abstract][Full Text] [Related]
7. Targeting both viral and host determinants of human immunodeficiency virus entry, using a new lentiviral vector coexpressing the T20 fusion inhibitor and a selective CCL5 intrakine.
Petit N; Dorgham K; Levacher B; Burlion A; Gorochov G; Marodon G
Hum Gene Ther Methods; 2014 Aug; 25(4):232-40. PubMed ID: 25045917
[TBL] [Abstract][Full Text] [Related]
8. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
[TBL] [Abstract][Full Text] [Related]
9. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
Bai J; Rossi J; Akkina R
AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
[TBL] [Abstract][Full Text] [Related]
10. CCR5 as a natural and modulated target for inhibition of HIV.
Burke BP; Boyd MP; Impey H; Breton LR; Bartlett JS; Symonds GP; Hütter G
Viruses; 2013 Dec; 6(1):54-68. PubMed ID: 24381033
[TBL] [Abstract][Full Text] [Related]
11. Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection.
Kimpel J; Braun SE; Qiu G; Wong FE; Conolle M; Schmitz JE; Brendel C; Humeau LM; Dropulic B; Rossi JJ; Berger A; von Laer D; Johnson RP
PLoS One; 2010 Aug; 5(8):e12357. PubMed ID: 20808813
[TBL] [Abstract][Full Text] [Related]
12. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
[TBL] [Abstract][Full Text] [Related]
13. Multiplexing seven miRNA-Based shRNAs to suppress HIV replication.
Choi JG; Bharaj P; Abraham S; Ma H; Yi G; Ye C; Dang Y; Manjunath N; Wu H; Shankar P
Mol Ther; 2015 Feb; 23(2):310-20. PubMed ID: 25358251
[TBL] [Abstract][Full Text] [Related]
14. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
[TBL] [Abstract][Full Text] [Related]
15. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.
Takashima K; Miyake H; Kanzaki N; Tagawa Y; Wang X; Sugihara Y; Iizawa Y; Baba M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3474-82. PubMed ID: 16048963
[TBL] [Abstract][Full Text] [Related]
16. Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev.
Cardona ME; Hinkula J; Gustafsson K; Christensson B; Wahren B; Mohamed AJ; Smith CIE; Arteaga HJ
Mol Biol Rep; 2022 Nov; 49(11):11187-11192. PubMed ID: 36098885
[TBL] [Abstract][Full Text] [Related]
17. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
[TBL] [Abstract][Full Text] [Related]
18. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.
Kim A; Pettoello-Mantovani M; Goldstein H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):145-9. PubMed ID: 9768623
[TBL] [Abstract][Full Text] [Related]
19. CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection.
Wang W; Ye C; Liu J; Zhang D; Kimata JT; Zhou P
PLoS One; 2014; 9(12):e115987. PubMed ID: 25541967
[TBL] [Abstract][Full Text] [Related]
20. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J; Akkina R
Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
